Mobile Delivery of PrEP at a Syringe Services Program-A Pilot Study
Latest Information Update: 18 Nov 2024
Price :
$35 *
At a glance
- Drugs Emtricitabine/tenofovir alafenamide (Primary)
- Indications HIV infections
- Focus Pharmacodynamics
- 13 Nov 2024 Status changed from active, no longer recruiting to completed.
- 12 Apr 2024 Planned End Date changed from 1 Nov 2024 to 1 Nov 2025.
- 12 Apr 2024 Planned primary completion date changed from 31 May 2024 to 31 May 2025.